Resolved

GLYCOPYRROLATE INJECTION USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLYCOPYRROLATE INJECTION USP in Canada?

Not currently. The most recent shortage report for GLYCOPYRROLATE INJECTION USP 4MG is marked resolved (last updated June 8, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength4MG

Last updated2026-06-08

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02473887

Strength

4MG

Dosage Form

SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

GLYCOPYRROLATE

Tier

Unrated

Last Updated

2026-06-08

Reason for Shortage

Delay in shipping of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890